Eli Lilly wins Alimta appeal at English Court of Appeal
The English Court of Appeal has ruled in favour of Eli Lilly, finding that a patent covering its blockbuster lung drug Alimta (pemetrexed disodium) would be infringed by a product proposed by Actavis, now Allergan.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk